EarningsBXPHARMA
BXPHARMA Earnings Update
Announcement summary
- What happened
- BXPHARMA published a corporate disclosure on 30 January 2019. Read the full announcement for details.
- Company
- Beximco Pharmaceuticals PLC.
- Announcement published
Original announcement
(Q2 Un-audited): Consolidated EPS was Tk. 1.81 for October-December, 2018 as against Tk. 1.66 for October-December, 2017; Consolidated EPS was Tk. 3.67 for July-December, 2018 as against Tk. 3.25 for July-December, 2017. Consolidated NOCFPS was Tk. 2.10 for July-December, 2018 as against Tk. 3.14 for July-December, 2017. Consolidated NAV per share was Tk. 69.15 as on December 31, 2018 and Tk. 63.77 as on December 31, 2017.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616aced55a6b00004005a933
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from BXPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.